Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
The Human Story Underneath the Data: Translating Clinical Rigor into Brand Strategy
In an interivew with Roastbrief US, Planning Director Elise Pietracatella explains how at AbelsonTaylor Group believes the science and the...
In the News Read more The Human Story Underneath the Data: Translating Clinical Rigor into Brand StrategyWhy the best agency relationships don’t start with an RFP
“Healthcare marketing remains a relationship business,” according to Justin Zylberman, Director of Business Development. Read his thoughts on the human element...
Learn More Read more Why the best agency relationships don’t start with an RFPThe Modern Agency: One Size Does Not Fit All
In an industry defined by constant change, the fundamentals still matter. In MM+M’s latest e-book, Jeff Berg, President of AbelsonTaylor Group,...
In the News Read more The Modern Agency: One Size Does Not Fit AllConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.